FDA cleared the ELEOS Limb Salvage System with NanoCept® Technology (Proximal Tibia) (AM-25002200-C) from Onkos Surgical, Inc. on Oct 29, 2026 under K263628, a special 510(k). The device falls under product code QZZ, Limb And Joint Salvage Device With Coating For Bacteria Reduction, regulated at 21 CFR 888.3900 as a Class 2 device. The review panel was Orthopedic.
FDA logged the submission as received on Sep 30, 2026. The decision came 29 days later, inside the 90 FDA-day goal for a 510(k).
Onkos Surgical, Inc. has one other decision in the tracker over the last 12 months: K253066 (ELEOS with NanoCept® Technology Limb Salvage System).
Questions & Answers
What did FDA clear under K263628?
K263628 is the FDA 510(k) for ELEOS Limb Salvage System with NanoCept® Technology (Proximal Tibia) (AM-25002200-C), submitted by Onkos Surgical, Inc.. FDA's decision date was Oct 29, 2026, under product code QZZ (Limb And Joint Salvage Device With Coating For Bacteria Reduction).
Who makes the ELEOS Limb Salvage System with NanoCept® Technology (Proximal Tibia) (AM-25002200-C)?
Onkos Surgical, Inc., based in Parsippany, NJ, is the applicant of record for K263628. The company is listed in the MedDevice Startups directory.
How long did the K263628 review take?
FDA received the submission on Sep 30, 2026 and issued its decision on Oct 29, 2026, 29 days later.